Compare OPEN & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OPEN | SHC |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 5.0B |
| IPO Year | 2020 | 2020 |
| Metric | OPEN | SHC |
|---|---|---|
| Price | $3.77 | $17.86 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $1.67 | ★ $20.33 |
| AVG Volume (30 Days) | ★ 76.1M | 2.9M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.09 |
| Revenue | ★ $4,371,000,000.00 | $1,163,617,000.00 |
| Revenue This Year | $3.04 | $7.51 |
| Revenue Next Year | $53.82 | $6.00 |
| P/E Ratio | ★ N/A | $197.83 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $1.70 | $11.00 |
| 52 Week High | $10.87 | $19.85 |
| Indicator | OPEN | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 36.87 | 55.17 |
| Support Level | N/A | $16.57 |
| Resistance Level | $5.58 | $17.80 |
| Average True Range (ATR) | 0.27 | 0.50 |
| MACD | -0.08 | -0.07 |
| Stochastic Oscillator | 9.38 | 55.03 |
Opendoor Technologies Inc is an end-to-end real estate platform enabling customers to sell and buy a home online. Its product offerings include Sell to Opendoor, its core product where sellers sell their homes directly to the company, and it resells those homes to buyers; List with Opendoor, for customers to list their homes with a partner agent; and Opendoor Marketplace, a capital-light marketplace offering that connects home sellers with both institutional and retail buyers. In addition to these products, the company also offers its customers integrated title insurance and escrow services through its subsidiaries. A vast majority of the company's revenue is generated by its core product offering, where it acquires homes directly from sellers and resells those homes to buyers.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.